首页 正文

Engineered MSCs secreting GLP-1 enhance β-cell survival and improve glycemic control in diabetic mice

{{output}}
Type 1 diabetes (T1D) arises from autoimmune destruction of pancreatic β-cells, leading to insufficient insulin production and impaired glucose regulation. Although insulin therapy and islet transplantation remain the primary treatment options, both are const... ...